Eosinophilic Esophagitis: Clinical Trials

234 trials for Eosinophilic Esophagitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

121 completed, 35 recruiting, 21 unknown, 17 active not recruiting. 50 Phase 2, 49 Not applicable, 28 Phase 3, 15 Phase 1, 11 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 250Completed 34, Recruiting 4, Terminated 4, Active not recruiting 3, Unknown 3, Withdrawn 2
Not applicable49Completed 20, Recruiting 7, Withdrawn 6, Terminated 5, Unknown 5, Not yet recruiting 3, Active not recruiting 2, Enrolling by invitation 1
Phase 328Completed 20, Active not recruiting 2, Terminated 2, Withdrawn 2, Recruiting 1, Unknown 1
Phase 115Completed 10, Withdrawn 2, Recruiting 1, Terminated 1, Unknown 1
Phase 411Completed 5, Active not recruiting 2, Unknown 2, Recruiting 1, Terminated 1
Early Phase 13Completed 2, Enrolling by invitation 1

Follow Eosinophilic Esophagitis: new trials by email Literature Review of Eosinophilic Esophagitis trials Research Report on Eosinophilic Esophagitis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Esophageal String Test as a Diagnostic Screening Tool for Eosinophilic Esophagitis Among Africans With Dysphagia in Mali and the United States
Esophageal string test - Dysphagia, Eosinophilic Esophagitis
Not applicableRecruitingNational Institute of Allergy and Infectious Diseases (NIAID)702026-11-012026-10-27
A Trial of Upadacitinib for Non-responsive Eosinophilic Esophagitis
Upadacitinib 30mg Dose, Upadacitinib Matching Placebo - EoE, Eosinophilic Esophagitis
Phase 2RecruitingUniversity of North Carolina, Chapel Hill522026-09-302026-10-06
Impact of Body Positioning on EndoFLIP Measurements: A Comparative Study of Supine and Left Lateral Decubitus Positions
EndoFlip - Dysphagia, Esophageal Stricture
Not applicableRecruitingJohns Hopkins University252026-07-242026-08-24
Elimination Diet Strategies and Histologic Remission in Children With Eosinophilic Gastrointestinal Disorders
Elimination Diet - Eosinophilic Gastrointestinal Disorders (EGID)
RecruitingCukurova University342026-07-012026-08-21
The DiNAM-EoE-C Study: Esophageal Distensibility and Novel Assessment of Motility in Eosinophilic Esophagitis
Eosinophilic Esophagitis (EoE), Dysphagia, Esophageal
Enrolling by invitationFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico252026-05-012026-07-29
Trial of Partial Enteral Nutrition With Dairy Free Diet in Eosinophilic Esophagitis
Partial enteral nutrition (PEN) with dairy elimination, Dairy elimination alone - Eosinophilic Esophagitis (EoE)
Not applicableRecruitingKate Farms Inc362026-03-182026-04-16
PRospective Registry of Esophageal Motility
No intervention - Esophageal Diseases, Achalasia
RecruitingIRCCS San Raffaele100002026-03-092026-04-02
Comparison of Eohilia With Dupixent on Esophagus Diameter in Patients With Eosinophilic Esophagitis.
Dupilumab 300 MG/2 ML Subcutaneous Solution [DUPIXENT], budesonide oral suspension - Eosinophilic Esophagitis (EoE)
Early Phase 1Enrolling by invitationMayo Clinic602026-02-042026-05-04
Utility of Mucosal Impedance Device in Chronic Esophageal Disorders:
MuVI Esophageal mucosal impedance testing - Gerd, Eosinophilic Esophagitis
RecruitingMedical College of Wisconsin502025-11-202026-07-27
A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis
dupilumab - Eosinophilic Esophagitis (EoE)
Phase 3RecruitingRegeneron Pharmaceuticals202025-11-102026-09-29
A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 Weeks
Vonoprazan, Placebo - Eosinophilic Esophagitis
Phase 2Active not recruitingPhathom Pharmaceuticals, Inc.952025-10-302026-10-13
Natural History of Eosinophilic Esophagitis in Adult and Pediatric Population
Eosinophilic Esophagitis (EoE)
RecruitingFondazione IRCCS Policlinico San Matteo di Pavia2002025-09-012026-06-29
Surface EMG Testing on Swallowing in EoE Patients
Surface Electromyography, Fiberoptic Endoscopic Evaluation of Swallowing - Eosinophilic Esophagitis (EoE)
Active not recruitingMayo Clinic302025-08-042026-07-17
Trans-Cervical and Trans-abdominal Ultrasound for Monitoring Esophageal Thickness in Eosinophilic Esophagitis
Trans cervical or abdominal ultrasound - Eosinophilic Esophagitis (EoE)
Not applicableNot yet recruitingSheba Medical Center1002025-08-012025-07-29
BURDEN OF ESOPHAGEAL CANCER IN EOSINOPHILIC ESOPHAGITIS (ESCAPE STUDY)
Eosinophilic Esophagitis (EoE)
CompletedIRCCS San Raffaele1000002025-07-232026-03-11
Local Clinical and Immunological Responses in Eosinophilic Esophagitis (EoE) Patients, Role of Mucosal Barrier Function and Type II Inflammation
Eosinophilic Esophagitis (EoE)
RecruitingAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)562025-07-012025-06-10
Prevalence and Description of FIRE (Food Induced Immediate Response of the Esophagus) in the Pediatric Population With Eosinophilic Esophagitis
Eosinophilic Esophagitis
RecruitingUniversity Hospital, Angers402025-07-012026-06-15
Comparing the Availability of AQ280 in the Body After Single Oral Doses of a Capsule Formulation Versus a Tablet for Oral Suspension Formulation
AQ280 Capsule, AQ280 Tablet for Oral Suspension, Placebo Capsule - Eosinophilic Esophagitis
Phase 1CompletedAQILION AB92025-06-132026-06-01
Umbilical Cord Blood Therapy in a Child With Eosinophilic Duodenitis and Autism Spectrum Disorder: a Case Study
Umbilical Cord Blood Infusion (Autologous and Allogeneic) - Autism Spectrum Disorder, Eosinophilic Gastrointestinal Disorders
Not applicableNot yet recruitingBundang CHA Hospital12025-06-012025-05-29
A Non-interventional Observational Study to Assess Long-term Efficacy and Safety of Dupilumab for the Treatment of Patients (>= 12 Years) With Eosinophilic Esophagitis Under Real-world-conditions in Germany
Dupilumab - Eosinophilic Esophagitis
RecruitingSanofi1502025-05-282026-09-17

Showing 20 of 234. Sign in to see all of them.

Narrower conditions

Esophagitis (24)  ·  Deglutition Disorders (18)  ·  Eosinophilic enteropathy (18)  ·  Gastroesophageal Reflux (16)  ·  Esophageal Diseases (13)  ·  Eosinophilia (11)  ·  Hypersensitivity (11)  ·  Food Hypersensitivity (10)  ·  Gastrointestinal Diseases (10)  ·  Gastroenteritis (8)  ·  Digestive System Diseases (6)  ·  Hematologic Diseases (5)  ·  Immune System Diseases (5)  ·  Leukocyte Disorders (5)

Broader conditions

Hemic and Lymphatic Diseases (234)  ·  Hypersensitivity, Immediate (230)  ·  Hematologic Diseases (229)  ·  Immune System Diseases (229)  ·  Leukocyte Disorders (229)  ·  Digestive System Diseases (228)  ·  Gastroenteritis (226)  ·  Gastrointestinal Diseases (224)  ·  Eosinophilia (223)  ·  Hypersensitivity (223)  ·  Esophageal Diseases (221)  ·  Esophagitis (210)  ·  Otorhinolaryngologic Diseases (22)  ·  Pathological Conditions, Signs and Symptoms (19)  ·  Pharyngeal Diseases (18)

Interventions

Fluticasone (17)  ·  dupilumab (15)  ·  Budesonide (12)  ·  Endoscopy, Digestive System (7)  ·  AK002 (6)  ·  APT-1011 (5)  ·  BID protein, human (4)  ·  cendakimab (4)  ·  Endoscopy (3)  ·  Esomeprazole (3)  ·  Omeprazole (3)  ·  Sodium Chloride (3)  ·  montelukast (3)  ·  Blood Specimen Collection (2)  ·  Dexlansoprazole (2)

Sponsors

Mayo Clinic (24)  ·  Children's Hospital Medical Center, Cincinnati (13)  ·  University of North Carolina, Chapel Hill (9)  ·  University of Colorado, Denver (8)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (7)  ·  Regeneron Pharmaceuticals (7)  ·  Allakos Inc. (6)  ·  Ann & Robert H Lurie Children's Hospital of Chicago (6)  ·  Dr. Falk Pharma GmbH (5)  ·  IRCCS San Raffaele (5)  ·  Shire (5)  ·  Celgene (4)  ·  Children's Hospital of Philadelphia (4)  ·  Ellodi Pharmaceuticals, LP (4)  ·  Massachusetts General Hospital (4)

Countries

United States (164)  ·  Italy (21)  ·  Canada (17)  ·  Germany (17)  ·  Switzerland (15)  ·  Spain (13)  ·  United Kingdom (12)  ·  Australia (11)  ·  Netherlands (11)  ·  Belgium (10)  ·  Israel (9)  ·  Poland (8)  ·  France (7)  ·  Japan (5)  ·  Austria (4)

Top investigators

Evan S Dellon, MD, MPH (8)  ·  Craig Paterson, MD (5)  ·  Joshua B Wechsler, MD (5)  ·  Marc E Rothenberg, MD, PhD (5)  ·  David Katzka, MD (4)  ·  Karthik Ravi, MD (4)  ·  Marc E. Rothenberg, M.D., Ph.D. (4)  ·  Calies Menard-Katcher, MD (3)  ·  Evan Dellon, MD, MPH (3)  ·  Ralph Mueller, PhD (3)  ·  Calman P Prussin, M.D. (2)

Results publications

PMID 42031097, PMID 28809387, PMID 34182150, PMID 36574003, PMID 37718471, PMID 39735351, PMID 41711386, PMID 41749054, PMID 10049409, PMID 16329022, PMID 17919504, PMID 19935783, PMID 20457157, PMID 20920599, PMID 22111863, PMID 22206777, PMID 22561055, PMID 22895393, PMID 23567357, PMID 24177377, PMID 24314292, PMID 24768678, PMID 24907494, PMID 24907502, PMID 24997328, PMID 25017104, PMID 25226850, PMID 25789989, PMID 25792708, PMID 26142551, PMID 26184697, PMID 26247167, PMID 26426817, PMID 26513622, PMID 26685124, PMID 27035377, PMID 27101536, PMID 27650328, PMID 27889574, PMID 28676207, PMID 29248733, PMID 29544738, PMID 29902649, PMID 30009819, PMID 30145316, PMID 30395812, PMID 30476587, PMID 30502508, PMID 30614939, PMID 30708107

NIH funding

U54AI117804 (4), 2014 (3), 2019 (2), UL1TR001082 (2), 2009 (1), 2016 (1), 2018 (1), K23DK090073 (1), K23DK129784 (1), R01CA103769 (1), R01DK091923 (1), R01DK101856 (1), R01DK114457 (1), R01DK132001 (1), R01DK135692 (1)